This week on the podcast we have the CEO and Founder of A28 Therapeutics Dr. Stanley T. Lewis.
A28 Therapeutics is a clinical-stage biopharmaceutical company focused on a new and very unique
platform to treat multiple cancer types.
In our discussion Dr. Lewis tells us about the challenges of launching a company, and the new skill sets he’s had to develop along the way.
